The Neuroprotective Effects of Exosomes Derived from TSG101-Overexpressing Human Neural Stem Cells in a Stroke Model

Although tissue-type plasminogen activator was approved by the FDA for early reperfusion of occluded vessels, there is a need for an effective neuroprotective drug for stroke patients. In this study, we established tumor susceptibility gene (TSG)101-overexpressing human neural stem cells (F3.TSG) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Eun-Jung, Choi, Yunseo, Kim, Tae Myoung, Choi, Ehn-Kyoung, Kim, Yun-Bae, Park, Dongsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455780/
https://www.ncbi.nlm.nih.gov/pubmed/36076942
http://dx.doi.org/10.3390/ijms23179532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455780/
https://www.ncbi.nlm.nih.gov/pubmed/36076942
http://dx.doi.org/10.3390/ijms23179532

Ejemplares similares